Skip to content
info@adcendo.dk
ADCendo Logo ADCendo Logo ADCendo Logo
  • Home
  • About
  • Our Technology And Target
  • Pipeline
  • Partnering and Investors
  • Team & Advisory Board
  • News
  • Contact
Loading...
  • ADCendo

    ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.

Home@angelh0lm2019-10-30T14:34:48+01:00
Go to Top